Atherosclerosis
Volume 193, Issue 2 , Pages 373-379 , August 2007

Association between serum albumin, carotid atherosclerosis, and metabolic syndrome in Japanese individuals

  • Nobukazu Ishizaka

      Affiliations

    • Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 3 3815 5411x37156; fax: +81 3 5842 5586.
    • ,
  • Yuko Ishizaka

      Affiliations

    • Center for Multiphasic Health Testing and Services, Mitsui Memorial Hospital, Tokyo, Japan
    • ,
  • Ryozo Nagai

      Affiliations

    • Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
    • ,
  • Ei-Ichi Toda

      Affiliations

    • Center for Multiphasic Health Testing and Services, Mitsui Memorial Hospital, Tokyo, Japan
    • ,
  • Hideki Hashimoto

      Affiliations

    • Department of Health Management and Policy, University of Tokyo Graduate School of Medicine, Tokyo, Japan
    • ,
  • Minoru Yamakado

      Affiliations

    • Center for Multiphasic Health Testing and Services, Mitsui Memorial Hospital, Tokyo, Japan

Received 3 January 2006 ,Revised 12 May 2006 ,Accepted 24 June 2006.

References 

  1. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet. 1989;2:1434–1436
  2. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15:458–482
  3. Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation. 2002;106:2919–2924
  4. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Fermo I, Foca A, et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens. 2000;18:1207–1213
  5. Malatino LS, Benedetto FA, Mallamaci F, Tripepi G, Zoccali C, Parlongo S, et al. Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients. J Nephrol. 1999;12:256–260
  6. Saito I, Yonemasu K, Inami F. Association of body mass index, body fat, and weight gain with inflammation markers among rural residents in Japan. Circ J. 2003;67:323–329
  7. Danesh J, Muir J, Wong YK, Ward M, Gallimore JR, Pepys MB. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J. 1999;20:954–959
  8. Gillum RF, Makuc DM. Serum albumin, coronary heart disease, and death. Am Heart J. 1992;123:507–513
  9. Hostmark AT, Tomten SE, Berg JE. Serum albumin and blood pressure: a population-based, cross-sectional study. J Hypertens. 2005;23:725–730
  10. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes. 2003;52:2346–2352
  11. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol. 2005;25:1038–1044
  12. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 2001;285:2486–97.
  13. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. Jama. 2004;291:451–459
  14. Rigaud D, Hassid J, Meulemans A, Poupard AT, Boulier A. A paradoxical increase in resting energy expenditure in malnourished patients near death: the king penguin syndrome. Am J Clin Nutr. 2000;72:355–360
  15. Shaper AG, Wannamethee SG, Whincup PH. Serum albumin and risk of stroke, coronary heart disease, and mortality: the role of cigarette smoking. J Clin Epidemiol. 2004;57:195–202
  16. Halliwell B. Albumin—an important extracellular antioxidant?. Biochem Pharmacol. 1988;37:569–571
  17. Wayner DD, Burton GW, Ingold KU, Locke S. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett. 1985;187:33–37
  18. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury. Part II. animal and human studies. Circulation. 2003;108:2034–2040
  19. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043–1046
  20. Ishizaka N, Ishizaka Y, Takahashi E, Yamakado M, Hashimoto H. High serum bilirubin level is inversely associated with the presence of carotid plaque. Stroke. 2001;32:580–583
  21. Salive ME, Cornoni-Huntley J, Phillips CL, Guralnik JM, Cohen HJ, Ostfeld AM, et al. Serum albumin in older persons: relationship with age and health status. J Clin Epidemiol. 1992;45:213–221
  22. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17:432–437
  23. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126
  24. Zhang WJ, Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res. 2002;55:820–829
  25. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis. 2005;181:381–388
  26. Iwasa M, Iwata K, Kaito M, Ikoma J, Yamamoto M, Takeo M, et al. Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in patients with chronic hepatitis C virus. Nutrition. 2004;20:368–371
  27. Cefalu WT, Wagner JD, Bell-Farrow AD, Edwards IJ, Terry JG, Weindruch R, et al. Influence of caloric restriction on the development of atherosclerosis in nonhuman primates: progress to date. Toxicol Sci. 1999;52:49–55
  28. Eriksson J, Taimela S, Koivisto VA. Exercise and the metabolic syndrome. Diabetologia. 1997;40:125–135

PII: S0021-9150(06)00397-2

doi: 10.1016/j.atherosclerosis.2006.06.031

Atherosclerosis
Volume 193, Issue 2 , Pages 373-379 , August 2007

Article Tools

* Image Usage & Resolution